Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery

Overview of attention for article published in Trials, January 2022

Altmetric Badge

Mentioned by

twitter: 12 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 81 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 21 X posts from 12 X users, with an upper bound of 31,077 followers.

RT @giovannilandoni: @sedar_es @fabiodoc64 @jaacc_online #poise3 #RCT just completed by @PHRIresearch @SRAnesthesiaICU will give important…

Reply Repost Favourite

@sedar_es @fabiodoc64 @jaacc_online #poise3 #RCT just completed by @PHRIresearch @SRAnesthesiaICU will give important answers on the management of perioperative medications to minimize hypotension @fabiodoc64 @YukiKotani5 https://t.co/m8hb1aZLc6

Reply Repost Favourite

RT @SRAnesthesiaICU: TRANEXAMIC ACID IN SURGERY 🩸 Should we use #TXA in all surgical patients worldwide to reduce bleeding? Also in patien…

Reply Repost Favourite

RT @PHRIresearch: #PHRI Senior Scientist PJ Devereaux @MacDeptMed @HEI_mcmaster @HamHealthSci will present #POISE3 findings on #TXA and no…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.